Many people in the global health field and in industry are curious, and some a bit skeptical, about what biotech can contribute to global health that academics and pharma aren't already providing. This roundtable discussion seeks to draw out specific examples of the meaningful ways that biotech companies can address global health and the benefits that companies stand to gain by venturing into developing world markets.



Objectives:

Educate audience members about where today's top discovery targets have useful applications for global health.

Discuss the benefits and hurdles of delivering products to developing world markets.

Highlight success stories of existing partnerships and innovative business models that support global health product development.